Hydroxychloroquine's role in preventing disease flares in autoimmune patients during pregnancy highlights its importance in maternal and fetal health. The ability of hydroxychloroquine cost to safely manage autoimmune activity without harming the fetus underscores the need for targeted research into its use in pregnant populations, ensuring optimal outcomes for both mothers and their babies.